Overview
The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 13 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.
Eligibility
Inclusion Criteria:
- Age 13 through 64 years
- Diagnosed with COVID-19 at least 2 months prior enrollment
- Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms
- Patients without COVID-19 diagnosis for controls
Exclusion Criteria:
- Received the influenza vaccine less than 4 months ago
- Pregnant or lactating
- Patients with special risks attendant to venipuncture
- Use of immunomodulatory medications that may impact vaccine immune response per clinician's judgment
- Contraindication to the flu vaccine
- Immunodeficiency or autoimmune disease that may impact vaccine immune responses per clinician's judgement